Literature DB >> 7278899

Emesis as a critical problem in chemotherapy.

J Laszlo, V S Lucas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7278899     DOI： 10.1056/NEJM198110153051609

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

1.  Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors.

Authors:  A Hamik; S J Peroutka
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  A systematic review and meta-analysis of intravenous palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults.

Authors:  Zhou Likun; Jing Xiang; Ba Yi; Duan Xin; Zheng Liu Tao
Journal:  Oncologist       Date:  2011-01-31

3.  Prescription trends of prophylactic antiemetics for chemotherapy-induced nausea and vomiting in Japan.

Authors:  Ayako Okuyama; Fumiaki Nakamura; Takahiro Higashi
Journal:  Support Care Cancer       Date:  2014-02-14       Impact factor: 3.603

4.  Comparison of starting antiemetic treatment 24 hours before or concurrently with cytotoxic chemotherapy.

Authors:  C J Williams; C Davies; M Raval; J Middleton; J Luken; B Stone
Journal:  BMJ       Date:  1989-02-18

5.  Alleviation of chemotherapy induced emesis by oral lorazepam and domperidone.

Authors:  P Warde; B Cantwell; J Fennelly; W Powderly; R Conroy
Journal:  Ir J Med Sci       Date:  1983-09       Impact factor: 1.568

6.  Levonantradol for the treatment of chemotherapy-induced nausea and vomiting.

Authors:  H H Gerhartz; T Binsack; E Hiller
Journal:  Klin Wochenschr       Date:  1983-07-15

7.  The gastrointestinal tract in chemotherapy-induced emesis. A final common pathway.

Authors:  O E Akwari
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

8.  A pilot study of adrenal suppression after dexamethasone therapy as an antiemetic in cancer patients.

Authors:  Hye-Suk Han; Young Kwang Shim; Jeong Eun Kim; Hyun-Jung Jeon; Sung-Nam Lim; Tae-Keun Oh; Ki Hyeong Lee; Seung Taik Kim
Journal:  Support Care Cancer       Date:  2011-08-18       Impact factor: 3.603

9.  Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy.

Authors:  J Latreille; D Stewart; F Laberge; P Hoskins; J Rusthoven; E McMurtrie; D Warr; L Yelle; D Walde; F Shepherd
Journal:  Support Care Cancer       Date:  1995-09       Impact factor: 3.603

10.  Chemotherapeutic agents do not interact with neurotransmitter receptors.

Authors:  S J Peroutka
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.